NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.52
-0.33 (-4.82%)
Oct 9, 2025, 4:00 PM EDT - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $18.30 million as of October 9, 2025. Its market cap has decreased by -53.27% in one year.
Market Cap
18.30M
Enterprise Value
-12.35M
1-Year Change
-53.27%
Ranking
Category
Stock Price
$6.52
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $18.30M, a decrease of -95.81%. That is a compound annual growth rate of -38.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 18.33M | -15.11% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |